Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03906526
Title A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 112 Birmingham Alabama 35294-3300 United States Details
University of Alabama at Birmingham Birmingham Alabama 35294-3300 United States Details
Boston University Boston Massachusetts 02215 United States Details
Local Institution - 116 Boston Massachusetts 02215 United States Details
Local Institution - 102 Saint Louis Missouri 63110 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of Cincinnati Cincinnati Ohio 45267-0501 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Local Institution - 101 Pittsburgh Pennsylvania 15232 United States Details
University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Local Institution - 103 Sioux Falls South Dakota 57104-8805 United States Details
Sanford Cancer Center Sioux Falls South Dakota 57104-8805 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field